Novartis NVS announced that the European Commission (“EC”) has approved its breast cancer drug Kisqali (ribociclib) for a ...

The European Commission has cleared use of CDK4/6 inhibitor Kisqali (ribociclib) to reduce the risk of recurrence in patients ...

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce ...

Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

Currently, treatment options for glioma are very limited. Even with a multi-modal approach combining surgical resection, ...